NCT05465226View on ClinicalTrials.gov

Oliceridine in Patients With Acute Burn Injuries

PHASE4CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

September 30, 2023

Study Completion Date

October 24, 2023

Conditions
Acute PainBurnsAdverse Drug EventRespiratory DepressionNausea and Vomiting, Postoperative
Interventions
DRUG

Oliceridine

see arm description

DRUG

Historical opioid use

Historical matched, control group in 2:1 ratio

Trial Locations (1)

38103

Regional One Health, Memphis

All Listed Sponsors
lead

University of Tennessee

OTHER